Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreAccelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreYour world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreFor government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreA curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREGet the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MOREMarket trends and dynamics impacting your U.S. business today and strategic plans for tomorrow.
Turning disruptors into advantages for a new model of commercial success.
A letter from the Editorial Board
We are in the midst of a remarkable moment for human health.
It is a moment built on the pandemic experience, but also on a rising tide of scientific discovery, data proliferation, and digital transformation. A moment where the opportunity to improve, to adapt, to progress is not only a vision, but also an imperative.
To get there, we’ll need deeper insights, healthy debate, and evidence-based thinking to create new solutions. To understand and embrace change. To sharpen our focus on what lies ahead.
But progress doesn't come from big ideas in isolation; transformation is almost never an individual endeavor. And so, we must also embrace cumulative improvement, collective adaptation, and exciting new intersections of expertise and skill to change the status quo and evolve how decisions are made.
Welcome to Progress Point, a curated collection of the latest intelligence from IQVIA on what's driving healthcare, and human health, forward in the U.S.
2023 is poised to be an important inflection point for much of healthcare in the United States. What’s on the horizon?
See trends and areas of change that pharmaceutical companies, and in particular commercial organizations, should consider.
IQVIA's Dr. Christina Mack sits down for a podcast conversation with Dr. Josh Sharfstein from Johns Hopkins Bloomberg School of Public Health to talk health, safety, and real-world implications of the NBA bubble findings.
Listen in on a moderated panel discussion with IQVIA leaders following the release of the IQVIA Institute’s annual global trend report on The Global Use of Medicines 2023.
Why new thinking and radical collaborations are required to adopt home healthcare at a larger scale.
